Leveraging Catalent's Integrated Network to Accelerate Spray Drying and Tableting Scale-Up
Summary: A biopharmaceutical company partnered with Catalent to develop and manufacture a commercially-viable, patient-friendly, stable tablet for a program intended to treat a disease that has unmet medical need. Catalent employed its OneXpress® Solution to reduce program risks and accelerate timelines by deploying phase appropriate technologies and expertise across its integrated network.